HAX Demo Day!! In Newark + Virtual. May 1. Register Now.

PONS creates disease progression insights that were never collected before.

Team

Soner Hacihaliloglu

CEO

Ilker Hacihaliloglu

CTO

PONS

Company details

PONS is an AI-driven software for ultrasound technology to improve the image quality significantly, create the first data on disease progress happening outside the hospital settings provide AI-driven risk assessment of disease progress, and enable early detection of diseases from cancer to heart defects, making lifesaving screening accessible to all communities, so complications can be treated early when outcomes matter most.

Get In Touch with PONS

Please tell us a little bit about yourself and why you'd like to get connected. PONS + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More